Aware Super Pty Ltd as trustee of Aware Super Decreases Stock Position in UnitedHealth Group Incorporated $UNH

Aware Super Pty Ltd as trustee of Aware Super cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,959 shares of the healthcare conglomerate’s stock after selling 184 shares during the quarter. Aware Super Pty Ltd as trustee of Aware Super’s holdings in UnitedHealth Group were worth $21,513,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in UNH. Aire Advisors LLC raised its stake in shares of UnitedHealth Group by 7.0% during the 2nd quarter. Aire Advisors LLC now owns 1,234 shares of the healthcare conglomerate’s stock valued at $385,000 after buying an additional 81 shares during the last quarter. WCM Investment Management LLC grew its stake in shares of UnitedHealth Group by 4.6% during the 2nd quarter. WCM Investment Management LLC now owns 1,271,535 shares of the healthcare conglomerate’s stock worth $393,044,000 after purchasing an additional 55,403 shares during the period. Turtle Creek Wealth Advisors LLC lifted its stake in shares of UnitedHealth Group by 144.4% in the 2nd quarter. Turtle Creek Wealth Advisors LLC now owns 23,198 shares of the healthcare conglomerate’s stock valued at $7,237,000 after purchasing an additional 13,707 shares during the period. WealthPlan Investment Management LLC grew its position in UnitedHealth Group by 23.3% during the second quarter. WealthPlan Investment Management LLC now owns 1,147 shares of the healthcare conglomerate’s stock valued at $358,000 after buying an additional 217 shares during the period. Finally, Alta Capital Management LLC raised its position in shares of UnitedHealth Group by 6.1% in the second quarter. Alta Capital Management LLC now owns 121,624 shares of the healthcare conglomerate’s stock worth $37,943,000 after acquiring an additional 7,006 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.2%

Shares of NYSE UNH opened at $360.77 on Thursday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a 50-day moving average of $325.04 and a 200 day moving average of $347.17. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The stock has a market cap of $326.73 billion, a PE ratio of 15.63, a P/E/G ratio of 2.33 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter last year, the company earned $6.80 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on UNH shares. Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Truist Financial increased their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Bank of America upped their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 8th. Piper Sandler cut their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Finally, Barclays raised their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Seventeen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $384.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.